… The Indian biotech industry is set to grow and occupy 140 … & Wakefield in its Bio Reality in India Report 2008. In addition to Bangalore, Hyderabad, …
Original post by EIN News: India Biotech News
… From correspondents in India, 09:01 PM IST India’s biotechnology major Biocon Ltd has acquired 70 percent … 70 percent stake in German pharmaceutical company AxiCorp GmbH for about $43.66 million, paving the …
Original post by EIN News: India Biotech News
… — Continued strong growth in Development/Small Scale business segment revenue, up 22% in fourth quarter, … 2006 resulting primarily from the acquisition of India Private Limited in June 2007 and increases … and development facility at the Shapoorji Pallonji Biotech Park in Hyderabad, India, providing additional space …
Original [...]
… industries, but also include the Alternative Fuels, Pharma-Biotech, and Pulp & Paper industries. Reporting in … factors continue to fuel the growth of industry in the country. Economists forecast China to … is India. With a stable political system, India is poised to become a major player …
Original [...]
… From correspondents in Maharashtra, India, 03:00 PM IST India’s biotechnology major Biocon Ltd has acquired 70 percent … 70 percent stake in German pharmaceutical company AxiCorp GmbH for approximately $43.66 million (Euro 30 …
Original post by EIN News: India Biotech News
… - Lipoxen PLC (AIM: LPX) a bio-pharmaceutical company specialising in the development of high value … co-developing products with the Serum Institute of India Limited (one of the world’s leading vaccine … the world’s leading vaccine companies, India’s largest biotech company and a major shareholder in Lipoxen) …
Original [...]
… The Indian drug industry, which has proven its strengths in manufacturing … said Shrikumar Suryanarayan, director general, Association of Biotechnology Led Enterprises (ABLE). adds that the diagnostic … for all diseases. He also feels that India can become a low-cost manufacturing base for …
Original post by EIN News: India [...]
The following appeal for generic biologic legislation was sent in from Insmed via youtube.
I’ve posted previously on the challenges of developing a framework for generic biologic approvals and questioned how much we can really expect to save. In the editorial for the upcoming issue of the Journal of Commercial Biotechnology, I argue that the [...]
… The Indian drug industry, which has proven its strengths in manufacturing … said Shrikumar Suryanarayan, director general, Association of Biotechnology Led Enterprises (ABLE). adds that the diagnostic … for all diseases. He also feels that India can become a low-cost manufacturing base for …
Original post by EIN News: India [...]
